Over the past couple of decades, enterprise resource planning (ERP) systems and associated technologies have garnered considerable traction across diverse industries beginning with the manufacturing sector. The promise of several gains accrued from the deployment of ERP system underpins its burgeoning popularity. The gains entail large efficiency improvements across business processes of organizations, streamlining communication across departments, better productivity, and the several strategic benefits to managers. Healthcare industry is no different. For long, healthcare organizations including hospitals world over are seeking ways to successfully implement ERP to boost operational efficiencies, notably with respect to key performance indicators (KPIs), and optimize cost, especially from their back-end operations.

The growing legal liabilities associated with medication errors have been reason enough for healthcare providers to invest in medication management systems. There is also a promising opportunity developing for medication management in homecare settings. While large multi-facility hospitals are the biggest users of medication management systems, smaller hospitals worldwide are warming up to the idea of streamlining their medication process as well. What works in the favor of the medication management market, however, is that implementation of such systems has become easier with the support of healthcare IT.

Oncology Information System Market by Software (Patient Information System & TPS), & Professional Service), Application (Medical, Radiation, & Surgical Oncology), End User (Hospital, Government Institution, & Research Center) - Global Forecasts

The global market is projected to reach USD 1,348.1 million by 2023 from USD 689.9 million in 2018, at a CAGR of 14.3% during the forecast period.

The Companion Diagnostic Market is expected to reach USD 6.51 Billion by 2022 from USD 2.61 Billion in 2017, at a CAGR of 20.1%.

The research report, titled “Global POS Terminals In The Hospitality Sector Market by Companies, Republics, Type and Application, Forecast to 2023,” presents a thorough and unbiased study of the past performance and the current status of this market, taking the prominent trends, important factors, challenges, opportunities, and the growth prospects into consideration.

The report illustrates a thorough overview of the current state of Healthcare Staffing Services with details like, functioning and designing, process involved in its manufacturing, availability in the market and its potential on the import, export and global sales of this popular product. In today’s global economic environment, it is very important for organizations to have an associated view of the data across the globe

The research antibodies market is segmented into pharmaceutical & biotechnological companies, academic & research institutes, and contract research organizations. The pharmaceutical & biotechnological companies segment is expected to grow at the highest CAGR during the forecast period.

The biobanking market is classified by storage type into manual and automated storage. The automated storage type segment is expected to grow at a higher rate during the forecast period.

The protein expression market is classified into insect cell expression systems; mammalian cell expression systems; prokaryotic expression systems, yeast expression systems; cell-free expression systems; and algal-based expression systems, on the basis of systems type.

The preimplantation genetic testing market is segmented into maternity centers & fertility clinics; hospitals, diagnostic labs, and service providers; and research laboratories & academic institutes.

The global cellular health screening market is segmented into blood samples and other samples. The blood samples segment is expected to dominate this market with the largest share in 2017.

The biologics safety testing market is classified on the basis of product & service into kits &reagents, services, and instruments. The kits & reagents segment is expected to register highest growth rate during the forecast period.

The global competent cells market is broadly segmented into cloning, protein expression, and other applications. The other applications segment is expected to register the highest CAGR during the forecast period.

The single-cell analysis market is segmented into consumables and instruments. Consumables are expected to register the highest CAGR during the forecast period.

The mycoplasma testing market is segmented into pharmaceutical and biotechnology companies, academic research institutes, contract research organizations (CROs), cell banks, and other end users.

The global microbiome sequencing services market is broadly segmented by technology, application, research type, laboratory type, end user, and region.

Geographically, the NGS-based RNA-seq market is segmented into North America, Europe, Asia-Pacific, and the Rest of the World. North America accounted for the largest share of the market in 2016, followed by Europe and Asia-Pasific. Asia-Pacific is expected to register the highest growth rate during the forecast period from 2017 to 2022, owing to focus on R&D activities and the low cost of NGS products & services in this region.

The global protein assays market is segmented based on type, product, technology, application, end user, and region. The protein assays market by product is segmented into reagents, kits, and instruments & accessories.

The protein engineering market is expected to grow at a double–digit CAGR of 15.7% to reach $1,463.0 million by 2020 from $705.5 million in 2015. Major factors fueling market growth are the increase in adoption of protein drugs over non-protein drugs, high prevalence rate of lifestyle diseases, growth in funding for protein engineering, and reduction in overall timeline and cost for drug discovery. However, expensive and high maintenance tools and instruments used in protein engineering and dearth of trained personnel are restricting the growth of the market.